Literature DB >> 15849485

Severe acute pancreatitis: case-oriented discussion of interdisciplinary management.

Pietro Renzulli1, Stephan M Jakob, Martin Täuber, Daniel Candinas, Beat Gloor.   

Abstract

The clinical course of an episode of acute pancreatitis varies from a mild, transitory illness to a severe often necrotizing form with distant organ failure and a mortality rate of 20-40%. Patients with severe pancreatitis, representing about 15-20% of all patients with acute pancreatitis, need to be identified as early as possible after onset of symptoms allowing starting intensive care treatment early in the disease process. An episode of severe acute pancreatitis progresses in two phases. The first 10-14 days are characterized by a systemic inflammatory response syndrome maintained by the release of various inflammatory mediators. The second phase, beginning about 10-14 days after the onset of the disease is dominated by sepsis-related morbidity due to infected peripancreatic and pancreatic necrosis. This state is associated with septic multiple organ systemic failure. The importance of infection on the outcome of necrotizing pancreatitis has been clearly delineated and the pre-emptive use of broad-spectrum antibiotics that achieve effective tissue concentrations is considered standard management of patients with severe necrotizing pancreatitis, especially if associated with organ failure or extended necrosis. Patients with infected necrosis should undergo a surgical intervention. The standard open technique consisting of an organ preserving necrosectomy followed by a postoperative concept of lavage and/or drainage to evacuate necrotic debris occurring during the further course has recently been challenged by various minimally invasive approaches.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15849485     DOI: 10.1159/000085266

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  14 in total

1.  Plasmapheresis in the treatment of hypertriglyceridemic pancreatitis with ARDS.

Authors:  Rajan S Kohli; Wissam Bleibel; Anil Shetty; Upendra Dhanjal
Journal:  Dig Dis Sci       Date:  2006-11-21       Impact factor: 3.199

2.  Acute pancreatitis--from cellular signalling to complicated clinical course.

Authors:  Roland Andersson; Bodil Andersson; Ellen Andersson; Jakob Axelsson; Gunilla Eckerwall; Bobby Tingstedt
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

3.  Influence of dexamethasone on inflammatory mediators and NF-kappaB expression in multiple organs of rats with severe acute pancreatitis.

Authors:  Xi-Ping Zhang; Ling Zhang; Lin-Jie Chen; Qi-Hui Cheng; Jian-Mei Wang; Wei Cai; Hai-Ping Shen; Jun Cai
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

4.  Interleukin-22 ameliorates acute severe pancreatitis-associated lung injury in mice.

Authors:  Ying-Ying Qiao; Xiao-Qin Liu; Chang-Qin Xu; Zheng Zhang; Hong-Wei Xu
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

5.  Role of intrapulmonary expression of inducible nitric oxide synthase gene and nuclear factor kappaB activation in severe pancreatitis-associated lung injury.

Authors:  Shi-hai Kan; Fei Huang; Jing Tang; Yun Gao; Chong-lin Yu
Journal:  Inflammation       Date:  2010-10       Impact factor: 4.092

6.  Rosiglitazone attenuates renal injury caused by hyperlipidemic pancreatitis.

Authors:  Rui Wang; Zhaopeng Yan; Xingmao Wu; Kaiqiang Ji; Haiyuan Wang; Bin Zang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

7.  Current status of minimally invasive necrosectomy for post-inflammatory pancreatic necrosis.

Authors:  Benoy Idicula Babu; Ajith Kumar Siriwardena
Journal:  HPB (Oxford)       Date:  2009-03       Impact factor: 3.647

8.  Gamma-enolase predicts lung damage in severe acute pancreatitis-induced acute lung injury.

Authors:  Lawrence Owusu; Caiming Xu; Hailong Chen; Geliang Liu; Guixin Zhang; Jinwen Zhang; Zhankai Tang; Zhongwei Sun; Xin Yi
Journal:  J Mol Histol       Date:  2018-05-04       Impact factor: 2.611

9.  Ethyl pyruvate significantly inhibits tumour necrosis factor-α, interleukin-1β and high mobility group box 1 releasing and attenuates sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury.

Authors:  Z-G Luan; J Zhang; X-H Yin; X-C Ma; R-X Guo
Journal:  Clin Exp Immunol       Date:  2013-06       Impact factor: 4.330

10.  Organ failure associated with acute pancreatitis in African-American and Hispanic patients.

Authors:  Magda A Shaheen; Abbasi J Akhtar
Journal:  J Natl Med Assoc       Date:  2007-12       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.